company background image
300878 logo

Zhejiang Wecome Pharmaceutical SZSE:300878 Stock Report

Last Price

CN¥17.47

Market Cap

CN¥2.5b

7D

-8.3%

1Y

-29.3%

Updated

24 Dec, 2024

Data

Company Financials

Zhejiang Wecome Pharmaceutical Company Limited

SZSE:300878 Stock Report

Market Cap: CN¥2.5b

300878 Stock Overview

Engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. More details

300878 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

Zhejiang Wecome Pharmaceutical Company Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zhejiang Wecome Pharmaceutical
Historical stock prices
Current Share PriceCN¥17.47
52 Week HighCN¥26.19
52 Week LowCN¥13.31
Beta0.14
1 Month Change-4.38%
3 Month Change21.57%
1 Year Change-29.27%
3 Year Change-36.06%
5 Year Changen/a
Change since IPO-61.20%

Recent News & Updates

Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%

Oct 09
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%

Recent updates

Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%

Oct 09
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%

Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected

Aug 02
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%

Mar 08
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%

Shareholder Returns

300878CN PharmaceuticalsCN Market
7D-8.3%-1.0%0.4%
1Y-29.3%-3.0%12.3%

Return vs Industry: 300878 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: 300878 underperformed the CN Market which returned 9.8% over the past year.

Price Volatility

Is 300878's price volatile compared to industry and market?
300878 volatility
300878 Average Weekly Movement11.3%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300878's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 300878's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20001,159Xiaoxia Kongwww.zjwk.com

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates distribution business, such as retail chains.

Zhejiang Wecome Pharmaceutical Company Limited Fundamentals Summary

How do Zhejiang Wecome Pharmaceutical's earnings and revenue compare to its market cap?
300878 fundamental statistics
Market capCN¥2.48b
Earnings (TTM)-CN¥33.29m
Revenue (TTM)CN¥458.47m

5.4x

P/S Ratio

-74.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300878 income statement (TTM)
RevenueCN¥458.47m
Cost of RevenueCN¥272.65m
Gross ProfitCN¥185.82m
Other ExpensesCN¥219.11m
Earnings-CN¥33.29m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.23
Gross Margin40.53%
Net Profit Margin-7.26%
Debt/Equity Ratio24.3%

How did 300878 perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

-99%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:35
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Wecome Pharmaceutical Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution